Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Fried

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Alimentary Pharmacology & Therapeutics|December 15, 2021
Editorial: targeting liver biopsy in NAFLD-the need to expand our non-invasive tools. Authors' replyHannah P Kim, Andrea R Mospan, Michael W Fried, et al.
Digestive Diseases and Sciences|April 11, 2012
Tangible resources for preparing patients for antiviral therapy for chronic hepatitis CJason E Bonner, A Sidney Barritt, Michael W Fried, et al.
Journal of Consulting and Clinical Psychology|June 27, 2012
Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?Donna M Evon, Carol E Golin, Michael W Fried, et al.
Digestive Diseases and Sciences|April 10, 2012
Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issuesJason E Bonner, A Sidney Barritt, Michael W Fried, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 9, 2004
Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United StatesMark W Russo, Joseph Galanko, Kimberly Beavers, et al.
Journal of Hepatology|July 20, 2020
Reply to: "HCV treatment in cirrhotic patients: Should we use a different approach for patients awaiting a liver transplant"Elizabeth C Verna, Lucy Akushevich, Monika Vainorius, et al.
The American Journal of Gastroenterology|September 18, 2008
Early predictors of anemia in patients with hepatitis C genotype 1 treated with peginterferon alfa-2a (40KD) plus ribavirinNancy Reau, Stephanos J Hadziyannis, Diethelm Messinger, et al.
Journal of Hepatology|December 15, 2010
Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infectionMichael W Fried, Stephanos J Hadziyannis, Mitchell L Shiffman, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 25, 2004
Liver transplantation for acute liver failure from drug induced liver injury in the United StatesMark W Russo, Joseph A Galanko, Roshan Shrestha, et al.
BMC Infectious Diseases|August 28, 2020
Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapyPeng Peng, Yanjuan Xu, Michael W Fried, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Alimentary Pharmacology & Therapeutics|December 15, 2021
Editorial: targeting liver biopsy in NAFLD-the need to expand our non-invasive tools. Authors' replyHannah P Kim, Andrea R Mospan, Michael W Fried, et al.
Digestive Diseases and Sciences|April 11, 2012
Tangible resources for preparing patients for antiviral therapy for chronic hepatitis CJason E Bonner, A Sidney Barritt, Michael W Fried, et al.
Journal of Consulting and Clinical Psychology|June 27, 2012
Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?Donna M Evon, Carol E Golin, Michael W Fried, et al.
Digestive Diseases and Sciences|April 10, 2012
Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issuesJason E Bonner, A Sidney Barritt, Michael W Fried, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 9, 2004
Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United StatesMark W Russo, Joseph Galanko, Kimberly Beavers, et al.
Journal of Hepatology|July 20, 2020
Reply to: "HCV treatment in cirrhotic patients: Should we use a different approach for patients awaiting a liver transplant"Elizabeth C Verna, Lucy Akushevich, Monika Vainorius, et al.
The American Journal of Gastroenterology|September 18, 2008
Early predictors of anemia in patients with hepatitis C genotype 1 treated with peginterferon alfa-2a (40KD) plus ribavirinNancy Reau, Stephanos J Hadziyannis, Diethelm Messinger, et al.
Journal of Hepatology|December 15, 2010
Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infectionMichael W Fried, Stephanos J Hadziyannis, Mitchell L Shiffman, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 25, 2004
Liver transplantation for acute liver failure from drug induced liver injury in the United StatesMark W Russo, Joseph A Galanko, Roshan Shrestha, et al.
BMC Infectious Diseases|August 28, 2020
Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapyPeng Peng, Yanjuan Xu, Michael W Fried, et al.
Pageof 17